Generate a tailored SOP for Dr. Daniel Landi. Improve your application with a focused, well-structured draft.
Daniel Bryce Landi is an Associate Professor in the Department of Pediatrics at Duke University and a member of the Duke Cancer Institute. His medical training includes a Hematology/Oncology Fellowship at Baylor College of Medicine from 2013 to 2016 and a pediatric internship and residency at Duke University from 2009 to 2012. He earned his M.D. from the University of Colorado, School of Medicine in 2009. Dr. Landi's research focuses on innovative treatment approaches for pediatric cancers, particularly those involving gliomas and craniopharyngiomas. He has been awarded numerous grants for clinical trials assessing various therapeutic interventions, including a phase 2 study of the systemic IL-6 receptor antagonist tocilizumab and a study of a novel peptide vaccine targeting CMV antigen in newly diagnosed pediatric high-grade gliomas. Dr. Landi is committed to advancing the understanding and treatment of pediatric cancer, emphasizing collaborative research and the development of new strategies to combat these diseases effectively.
Duke University • Durham, NC
Associate Professor in the Department of Pediatrics and member of the Duke Cancer Institute.
Duke University • Durham, NC
Assistant Professor in the Department of Pediatrics.
Department of Biomedical Engineering (MS program)